RIVERNORTH CAPITAL MANAGEMENT, LLC - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is ORIAW and the CUSIP is G6780C117. A total of 32 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RIVERNORTH CAPITAL MANAGEMENT, LLC ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$2,753
-50.0%
34,4100.0%0.00%
Q4 2022$5,506
-8.2%
34,4100.0%0.00%
Q3 2022$6,0000.0%34,4100.0%0.00%
Q2 2022$6,000
-53.8%
34,4100.0%0.00%
Q1 2022$13,000
-61.8%
34,410
-1.7%
0.00%
-100.0%
Q4 2021$34,000
+9.7%
34,9970.0%0.00%
-50.0%
Q3 2021$31,00034,9970.00%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q2 2022
NameSharesValueWeighting ↓
Empery Asset Management, LP 40,000$46,0000.10%
ANGELO GORDON & CO., L.P. 60,000$580,0000.05%
Radcliffe Capital Management, L.P. 80,000$780,0000.02%
Anson Funds Management LP 15,000$145,0000.01%
CANTOR FITZGERALD, L. P. 162,945$156,0000.01%
Arena Capital Advisors, LLC- CA 120,000$115,0000.01%
AQR Arbitrage LLC 40,000$387,0000.01%
MMCAP International Inc. SPC 160,000$154,0000.01%
Segantii Capital Management Ltd 30,000$290,0000.01%
Atalaya Capital Management LP 100,000$96,0000.01%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders